1. Heart Protection Study Collaborative Group Lancet 2011;377:469-76

2. Patient characteristics by baseline concentration of CRP
Heart Protection Study Collaborative Group Lancet 2011;377:469-76

3. Effect of simvastatin allocation on changes in concentrations of LDL cholesterol and CRP between baseline and final year of follow-up
Heart Protection Study Collaborative Group Lancet 2011;377:469-76

4. Effect of simvastatin allocation on vascular events by baseline concentration of C-reactive protein
Heart Protection Study Collaborative Group Lancet 2011;377:469-76

5. Effect of simvastatin allocation on vascular and non-vascular death by concentration of baseline C-reactive protein
Heart Protection Study Collaborative Group Lancet 2011;377:469-76

6. Effect of simvastatin allocation on first major vascular event during follow-up by baseline concentrations of LDL cholesterol and CRP
Test for heterogeneity between four groups, excluding participants with missing data for baseline CRP concentration. Threshold values used to define low and high concentrations of LDL cholesterol and CRP are from the median values in the hypothesis-generating trial.
Heart Protection Study Collaborative Group Lancet 2011;377:469-76